Amanda Hemmerich, M.D., FCAP
Global Director of Digital Pathology Innovation, Surgical, Molecular, and Cytopathologist
IQVIA Laboratories is expanding its digital pathology capabilities through a strategic collaboration with OracleBio, a specialist in AI driven image analysis for histopathology. The collaboration enhances IQVIA Laboratories’ ability to support advanced pathology driven insights within clinical research programs through the integration of AI enabled analytics and expert scientific oversight.
As clinical trials increasingly rely on complex tissue-based endpoints, sponsors are seeking approaches that can extract deeper insight from pathology samples while maintaining scientific rigor, consistency, and regulatory readiness. This collaboration brings together complementary expertise to help translate complex pathology data into meaningful clinical insight.
Strengthening Digital Pathology With Advanced Image Analysis
OracleBio brings specialized expertise in AI powered image analysis, including the development and application of algorithms designed to extract quantitative insights from whole slide images. These capabilities extend IQVIA Laboratories’ existing anatomic pathology and digital pathology services by enabling more detailed analysis of cellular and spatial features within tissue samples, such as quantifying immune cell distribution, tumor microenvironment characteristics, or biomarker expression patterns at scale.
By integrating OracleBio’s image analysis services into IQVIA Laboratories’ workflows, sponsors can access advanced analytics within a cohesive clinical research environment. Patient samples, digital images, and analytical outputs are aligned to support clearer interpretation of disease biology and treatment response across studies.
Enabling Faster, More Confident Clinical Decisions
Incorporating AI driven image analysis earlier and more consistently within clinical trials allows sponsors to generate richer datasets that support biomarker discovery, patient stratification, and endpoint assessment. Advanced image analytics, combined with expert pathology review, help reduce manual processes while improving analytical precision and reproducibility.
This approach accelerates access to high quality pathology data and supports more confident clinical decision making throughout development. Clearer insight into tissue level changes and spatial biology helps sponsors evaluate therapeutic mechanisms, assess response, and refine study strategies with greater certainty.
Over time, improved data quality and consistency contribute to more efficient trial execution and better informed development decisions, helping promising therapies progress with greater confidence.
Translating Pathology Insight Into Patient Impact
Detailed analysis of tissue architecture and cellular interactions plays a critical role in understanding disease mechanisms and treatment response. The combined capabilities of IQVIA Laboratories and OracleBio enable deeper exploration of spatial biology, supporting the development of more targeted and precise therapeutic strategies.
By improving how pathology data is generated, analyzed, and interpreted within clinical research, the collaboration helps sponsors make decisions that are more closely aligned to biological evidence. These improvements ultimately support the development of therapies that are more likely to benefit patients and address unmet medical needs.
Continuing to Advance Digital Pathology Capabilities
This collaboration reflects IQVIA Laboratories’ continued investment in advanced technologies that enhance the value of laboratory data across the drug development lifecycle. Working with OracleBio extends IQVIA Laboratories’ digital pathology capabilities with specialized image analysis expertise that supports evolving clinical research requirements.
Together, IQVIA Laboratories and OracleBio are advancing a more connected, data driven approach to pathology that strengthens clinical insight, improves efficiency, and supports progress toward better outcomes for patients worldwide.
Want to learn more? Connect with our team.